2.85
price down icon4.04%   -0.12
after-market  시간 외 거래:  2.87  0.02   +0.70%
loading

Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스

Organogenesis reports Q1 EPS (2c), consensus (3c) - TipRanks.com - TipRanks

pulisher
TipRanks

Organogenesis Holdings Inc (ORGO) looking to reclaim success with recent performance – Sete News - SETE News

pulisher
SETE News

Organogenesis Holdings Inc (ORGO) stock analysis: A simple moving average approach – US Post News - US Post News

pulisher
US Post News

Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested a year ago - Yahoo Movies UK

pulisher
Yahoo Movies UK

Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

pulisher
Simply Wall St

Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

pulisher
Yahoo Finance

Organogenesis (NASDAQ:ORGO) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

pulisher
MarketBeat

Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ... - Yahoo Finance

pulisher
Yahoo Finance

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Earnings call: Organogenesis exceeds Q1 expectations, eyes ReNu progress - Investing.com

pulisher
Investing.com

Organogenesis (ORGO) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Skin Replacement and Substitute Market Size (Revenue) | Acelity L.P. Inc., MiMedx Group Inc., Organogenesis Inc. - Motions Online

pulisher
Motions Online

Organogenesis (ORGO) to Release Earnings on Thursday - Defense World

pulisher
Defense World

Organogenesis (ORGO) to Release Earnings on Thursday - Defense World

pulisher
Defense World

The Organogenesis Holdings (NASDAQ:ORGO) Share Price Is Up 330% And Shareholders Are Delighted - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK

pulisher
Yahoo Movies UK

Organogenesis Phase 3 ReNu OA study meets primary endpoint (NASDAQ:ORGO) - Seeking Alpha

pulisher
Seeking Alpha

Organogenesis (ORGO) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat

pulisher
MarketBeat

Organogenesis achieves primary endpoint in Phase 3 trial of ReNu - TipRanks.com - TipRanks

pulisher
TipRanks

Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price - Simply Wall St

pulisher
Simply Wall St

Are Organogenesis Holdings Inc (ORGO) shares a good deal now? – US Post News - US Post News

pulisher
US Post News

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

pulisher
GlobeNewswire Inc.

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

pulisher
GlobeNewswire Inc.

Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations - Yahoo Finance

pulisher
Yahoo Finance

Why Organogenesis Holding Stock Plummeted by 18% Today

pulisher
The Motley Fool

Why Organogenesis Holding Stock Plummeted by 18% Today - The Motley Fool

pulisher
The Motley Fool

Organogenesis (ORGO) Q4 2023 Earnings Call Transcript

pulisher
The Motley Fool

Organogenesis (ORGO) Reports Break-Even Earnings for Q4

pulisher
Zacks Investment Research

Organogenesis (ORGO) Q4 2023 Earnings Call Transcript - The Motley Fool

pulisher
The Motley Fool

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

pulisher
GlobeNewswire Inc.

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic ... - Yahoo Finance

pulisher
Yahoo Finance

Foghorn Therapeutics Inc. (FHTX) Moves 22.7% Higher: Will This Strength Last?

pulisher
Zacks Investment Research

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

pulisher
GlobeNewswire Inc.

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 - GlobeNewswire

pulisher
GlobeNewswire

HRMY: 4 Biotech Stocks With Massive Buy Potential - StockNews.com

pulisher
StockNews.com

Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice

pulisher
Zacks Investment Research

Have Organogenesis Holdings Insiders Been Selling Stock? - Simply Wall St

pulisher
Simply Wall St

ORGO: 3 Biotech Stocks to Keep an Eye on in 2024 - StockNews.com

pulisher
StockNews.com

Best Momentum Stocks to Buy for January 5th

pulisher
Zacks Investment Research

New Strong Buy Stocks for January 5th

pulisher
Zacks Investment Research

Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?

pulisher
Zacks Investment Research

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

pulisher
Benzinga

VRTX: 3 Biotech Stock Buys to Supercharge Your Portfolio - StockNews.com

pulisher
StockNews.com

The Zacks Analyst Blog Highlights Organogenesis, Riskified, Hooker Furniture, Stoneridge and VirTra

pulisher
Zacks Investment Research

5 Reasons Why Small-Cap Stocks Can Surge in 2024: 5 Top Picks

pulisher
Zacks Investment Research

ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of ... - Business Wire

pulisher
Business Wire

Here Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)

pulisher
Zacks Investment Research

Organogenesis (ORGO) Q3 2023 Earnings Call Transcript - The Motley Fool

pulisher
The Motley Fool

BMRN: 3 Brilliant Biotech Stocks to Buy for Your Portfolio - StockNews.com

pulisher
StockNews.com
$66.53
price down icon 0.46%
$16.98
price down icon 0.35%
$55.25
price down icon 0.65%
drug_manufacturers_specialty_generic RDY
$69.30
price down icon 0.50%
$11.02
price down icon 0.45%
$141.91
price down icon 0.06%
자본화:     |  볼륨(24시간):